confocal laser endomicroscopy (cle) … · 1 3 2 anti-reflux surgery see clearly, act faster...

4
1 3 2 ANTI-REFLUX SURGERY SEE CLEARLY, ACT FASTER CONFOCAL LASER ENDOMICROSCOPY (CLE) HD White Light Endoscopy X 30 MACROSCOPIC ANALYSIS Histology BIOPSY: MICROSCOPIC ANALYSIS Cellvizio X 1000 ENDOMICROSCOPIC ANALYSIS Cellvizio MINIPROBE LIVE Cellvizio provides real-time vision at the cellular level

Upload: vutram

Post on 07-Sep-2018

218 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: CONFOCAL LASER ENDOMICROSCOPY (CLE) … · 1 3 2 anti-reflux surgery see clearly, act faster confocal laser endomicroscopy (cle) hd white light endoscopy x 30 macroscopic analysis

1

3

2

ANTI-REFLUX SURGERY

SEE CLEARLY, ACT FASTER

CONFOCAL LASER ENDOMICROSCOPY (CLE)

HD White Light Endoscopy

X 30 MACROSCOPIC

ANALYSIS

HistologyBIOPSY: MICROSCOPIC

ANALYSIS

Cellvizio

X 1000 ENDOMICROSCOPIC

ANALYSIS

Cellvizio

MINIPROBELIVE

Cellvizio provides real-time vision at the cellular level

Page 2: CONFOCAL LASER ENDOMICROSCOPY (CLE) … · 1 3 2 anti-reflux surgery see clearly, act faster confocal laser endomicroscopy (cle) hd white light endoscopy x 30 macroscopic analysis

Intestinal metaplasia1

Dysplasia1

Squamous epithelium1

The Confocal Laser Endomicroscopy (CLE) solution

Rule-in or Rule-out Intestinal Metaplasia with more diagnostic accuracy

Real-time in-vivo cellular imaging

Rule-in or Rule-out Intestinal Metaplasia with 98% sensitivity and 96% NPV1

Improve on the inefficient random sampling and low, 6% diagnostic yield provided by current techniques4

Better understand the disease state of the Esophagus, thus enabling better patient care management2,3

Kiesslich Study, 63 patients, monocentric3

Sen

siti

vity

98%

Neg

ativ

e P

red

icit

ive

valu

e

96

%

6% yield with current techniques

Adding CLE to standard practice can help:

THE CLINICAL BENEFITS

Canto Study, 192 patients, multi-centric4

1. Kiesslich R. et al. In Vivo Histology of Barrett’s Esophagus and Associated Neoplasia by Confocal Laser Endomicroscopy. Clinical Gastro and Hepatology, 2006. 2. Sharma P. et al. Real-time Increased Detection of Neoplastic Tissue in Barrett’s Esophagus with probe- based Confocal Laser Endomicroscopy: Final Results of a Multi-center Prospective International Randomized Controlled Trial. Gastrointestinal Endoscopy, 2011 (DONT BIOPCE). 3. Bertani H. et al. Improved Detection of Incident Dysplasia by pCLE in a BE Surveillance Program. Dig Dis Sci, 2013. 4. M. Canto, et al. In vivo endomicroscopy improves detection of Barrett’s esophagus–related neoplasia: a multicenter international randomized controlled trial, GIE 2013.

Compatible operating channel Length Maximum # of uses Field of view Resolution Confocal depth

≥ 2.8 mm 3 m 20 Ø 240 µm 1 µm 55 to 65 µm

GastroFlex™ UHD Miniprobe

Cleared intended use: The Cellvizio® 100 Series System with GastroFlex UHD™ is a confocal laser system with fiber optic probes that is intended to allow imaging of the internal microstructure of tissues in anatomical tracts, i.e., gastrointestinal, accessed by an endoscope or endoscopic accessories.

Page 3: CONFOCAL LASER ENDOMICROSCOPY (CLE) … · 1 3 2 anti-reflux surgery see clearly, act faster confocal laser endomicroscopy (cle) hd white light endoscopy x 30 macroscopic analysis

5. ASGS Position Statement: Review of Confocal Laser Endomicroscopy, 2016. 6. Sharma P et al. White Paper AGA: Advanced Imaging in Barrett’s Esophagus. Clin Gastroenterol Hepatol. 2015. 7. Webcontent contribution from the College of American Pathologists website. 8 SAGES Guidelines for Surgical treatment of Gastroesophageal Reflux Disease (GERD) February 2010.

Physician’s Testimonials

“With esophageal cancer rates having increased by 600% since the introduction of powerful acid reducing medications, the accurate detection and determination of extent of Barrett’s is greatly enhanced by Cellvizio.”Courtesy of JF. Paul (Tripp) Buckley, MD

Diagnostic accuracy

Digital Biopsy Monitoring

CLEAR

Guidelines for surgical treatment of GERD SAGES 2010

According to the guidelines: “A finding of high-grade intraepithelial neoplasia or adenocarcinoma on preoperative biopsy requires immediate attention and may delay or exclude surgery.8”

Use of Cellvizio may thus improves patient’s managment for selected patients1-3

“Cellvizio makes it possible for us to: rule-in or rule-out the presence of pre-cancerous cells (...) perform improved surgical intervention (...) monitor for the presence of cancerous cells after the procedure.”Courtesy of Joseph J. Burnette, MD, Coliseum Northside Hospital

Society support

“…workshop panelists agreed that in the hands of endoscopists who have met the PIVI thresholds with specific enhanced imaging techniques (NBI & CLE), use of the technique in BE patients is appropriate!6” American Gastroenterological Association - White Paper

“Cellvizio®, very clearly, is integral to the comprehensive assessment of patients suffering from reflux disease!5”

American Society of General Suregons - Position Statement

“In Vivo Microscopy (IVM) can help target higher-yield, more diagnostic sites!7” College of American Pathologists

Society support and testimonials

o

o

Page 4: CONFOCAL LASER ENDOMICROSCOPY (CLE) … · 1 3 2 anti-reflux surgery see clearly, act faster confocal laser endomicroscopy (cle) hd white light endoscopy x 30 macroscopic analysis

EXPERIMENT

o Proctorship

o Dinner Workshop

DEVELOPMENT

o In-Service

o Cellvizio Days

o Case Support

EXPERTISE

o Testing

o Certifications

Cellvizio® Academy

Cel

lviz

io G

ER

D B

roch

ure

US

© M

auna

Kea

Tec

hnol

ogie

s, J

anua

ry 2

017

, v2.

00

EUROPEMauna Kea Technologies SA 9, rue d’Enghien75010 Paris, FranceTel : + 33 1 48 24 03 45 Fax : +33 1 48 24 12 18

NORTH AMERICAMauna Kea Technologies, Inc. 24 Denby Road, Unit 140Allston, MA, USATel : +1 (678) 731 7544Fax : +1 (888) 797 6640Toll free : + 1 (888) 590 1798

CELLVIZIO.NET MAUNAKEATECH.COM

[email protected]

The Cellvizio® Systems are regulated Medical Device, CE marked (Class IIa - NB : LNE/G-MED) and FDA cleared; Cellvizio systems are intended to allow confocal laser imaging of the internal microstructure of tissues in anatomical tracts, i.e. gastrointestinal, respiratory or urinary, accessed through an endoscope or endoscopic accessories. These statements and the associated references to specific clinical studies, are not intended to represent claims of safety or effectiveness for detecting or treating any specific condition or disease state. Rather this information is intended to provide useful reference to selected published literature describing physician experiences with the associated clinical uses. These statements have not been reviewed, cleared, or approved by the U.S. FDA. Please note that the interpretation criteria are suggested descriptive features and do not represent definitive diagnostic landmarks and are a result of input from trained and well qualified person. Any diagnostic assessment should always be made by the attending physician, based on the evaluation of all sources of clinical, endoscopic and other relevant information. Please consult labels and instructions for use.

A dedicated training website: cellvizio.net Best in Class Educationals Events A robust implementation program with case support

550 40 900+Cellvizio installed…

CELLVIZIO WORLDWIDE

…in more than forty countries Peer reviewed publications on endomicroscopy

150 250 150

DISCOVERY

o Cellvizio.net

o Webinars

o Remote Proctorships

RAPID LEARNING CURVE